Introduction
Lymphoma of the gastroinestinal tract comprises a group of rare diseases which have excited attention because of their potential curability-e. Abdominal lymphoma is predominantly of the non-Hodgkin type (NHL), and initial management is often undertaken by a general surgeon who may have had little or no experience of the disease. Presentation oflymphoma as a primary gastrointestinal disorder is rare, with an estimated incidence of 1.6 per 100,000 each year in Britain". Figures from the literature indicate that NHL represents about 1% of all malignant gastrointestinal tumoursv'. It occurs rarely in the colon and rectum (0.4% of colorectal tumours), less rarely in the stomach (2.5% of gastric neoplasms), and relatively commonly in the small intestine (20% of all neoplasrnsf'".
Because the disease is so uncommon, it is difficult for large numbers of patients to be accrued at any single centre. Blackledge and colleagues described 104 patients treated at the Christie Hospital between 1950 and 1975 2 • They pointed out that unlike lymphoma of the reticuloendothelial system, malignant lymphoma which arises from lymphoid tissue associated with the gut has a propensity to remain localized to the gastrointestinal wall and its draining lymph nodes, and that spread outside this system is rare. This explains instances of survival after excisional surgery alone. Currently there is evidence that prognosis is improved by chemotherapy after operation'', The purpose of this study was to investigate the role that surgeons have in the management of this disease from the outset.
Patients and methods
The mode of presentation, treatment and outcome were reviewed for 55 adult patients treated at the Christie Hospital between 1975 and 1984. They were selected for study on the basis that each had presented initially to a surgeon, and had undergone surgery in District General hospitals for abdominal symptoms and signs. Clinical characteristics are shown in Table 1 . In 22 patients (40%)the initial operation was performed as an emergency; in 33 (60%) it was an elective procedure. After initial operation all were referred to the Christie Hospital for combination chemotherapy, and any further surgery was performed there. Staging investigations included bone marrow examination, computed tomography of the chest and abdomen, and barium studies of the gastrointestinal tract where appropriate. Selection of chemotherapy was according to stage, and the protocol has been described", Histopathology was reviewed using a modified Rappaport classification", then the Kiel classification, with additional immunoperoxidase studies for the diagnosis of histiocytic lymphoma" ( Table 2 ). Factors evaluated included mode of presentation, findings at operation (both first and subsequent procedures), site of disease, extent of surgical resection, incidence and nature of complications, and overall survival. All statistical analysis was performed by means of the Chi-squared and Fisher's exact tests. 
Site of disease
The small intestine and upper gastrointestinal tract were more commonly involved than the large bowel ( Table 3 ). In 17 (31%) patients there was more than one site of gastrointestinal disease. antagonists until complications such as haematemesis, perforation, or the appearance of a palpable mass demanded a change in management. Four patients with weight loss, chronic abdominal pain, diarrhoea and malabsorption were thought initially to have Crohn's disease, and were treated appropriately for that condition. Persistence of symptoms and deterioration in spite of medication were the reasons for laparotomy. Five patients presented with chronic diarrhoea alone, which was investigated in all cases, but no diagnosis had been made. They were treated symptomatically until they developed the complications for which laparotomy was indicated.
Survival
There were 44 patients in whom it was possible to assess survival for three years or more after operation. Survival was assessed with regard to age, sex, site of disease, histopathology, elective or emergency operation, and extent of surgical resection. Only the site of disease and extent of resection correlated with survival.
There was a highly significant difference in survival between those in whom surgical resection was complete compared with those who underwent biopsy alone (Chi-squared=32.291, P<O.OOOl). In 16 (29%) patients the surgeon at the time ofoperation described the resection of obvious diseased tissue as 'complete'. Fourteen (87%)of these survived three years or more. Four of them after operation had evidence of retroperitoneal node involvement on CT scan, but this did not affect survival. In 28 patients complete resection of disease was not performed, and only one survived to three years after operation ( Table 5 ).
The majority of deaths occurred within one year of operation (22 of 29, 74%). Sixteen patients in this first year died from gastrointestinal complications which arose after the postoperative period, during chemotherapy (16 of 22, 73%). Fifteen of these deaths occurred in the group which had not had 'complete' resection: seven from haemorrhage, four from perforation, and four from intestinal obstruction ( Table 5 ). In all of these the source of the complications was residual disease in the intestinal wall. Complications did not occur in patients without mural disease.
Only one of the 16 deaths occurred in the group who had had 'complete' resection: this was a male who succumbed to intestinal perforation due to pseudomembranous colitis. At postmortem examination there was no evidence of recurrent lymphoma. One other complication occurred in the same groupintestinal obstruction due to adhesions in one patient was successfully remedied by further operation.
Survival by site of disease must be viewed with caution because of the small numbers of patients in 
Presentation and diagnosis
The modes of presentation are shown in Table 4 . Elective operations were most commonly performed for abdominal pain, weight loss, or a palpable abdominal mass, and many patients presented with more than one symptom. In all patients the initial operation was performed without knowledge of the correct diagnosis. In 32 patients (58%) no diagnosis had been made before operation, which was performed relatively early in their course of symptoms. The remainder, 23 (42%) were misdiagnosed, and in these patients there was a delay in correct diagnosis of~6 months from the start of symptoms. This delay was commonly after referral to a specialist, and in 17 (31%)the delay had been a year or longer. Fourteen patients were thought to have peptic ulcer -all had had barium meal studies which had suggested ulceration, and 10 had undergone endoscopy. Endoscopic ulcer biopsy did not reveal the true diagnosis in any patient. They were treated, often for many months, with antacids and H 2 receptor Table 3 . Site of disease More than one site of disease each group, but there were apparently fewer survivors (2 of 9) in those with colonic disease compared with those with upper gastrointestinal tract disease (10 of 18). This trend did not achieve significance (Fisher's exact test, P=0.21).
Second operations
Latterly second laparotomy has been performed within three years offollow-up on 5 of 11 patients who had had biopsy only at the first procedure. CT scans suggested that the gastrointestinal disease was localized and amenable to surgical resection. 'Complete' resection was possible for these patients at the second operation. None of these patients was evaluable for survival at~3 years, but they did not have complications during chemotherapy, and all were alive at the time of review.
Histology
We did not find any association between histopathology and outcome in this series. But numbers in all groups were small ( Table 2 ). Other workers have found that prognosis is not influenced by histological type 9-11 •
Discussion
The incidence of GIL by site in this study is in agreement with previously published series. In over half, the stomach was the major site of disease, in a quarter the small intestine was affected, and in the rest, the large intestine and lymph nodeslO.12-19. Some of these reports suggest that gastric lymphoma has the best prognosis, particularly if complete resection is achievedl.20.21. We did not confirm any survival advantage by site, and this is in agreement with some other reports 6.23.
The problem of diagnostic difficulty in patients with gastrointestinal lymphoma (GIL) has received limited attention, but some reports suggest the finding that preoperative diagnosis of GIL is unusuap·22. In the study reported by Lim, only five of 50 patients with GIL were diagnosed before operationv'. None of the patients in our study had a correct diagnosis before operation. Diagnostic difficulties occur in part because non-specific symptoms of abdominal pain, nausea, vomiting and weight loss are often caused by a large number of common conditions, whereas GIL is rare 23 .
In this study we found that misdiagnosis delayed the correct treatment for over six months in almost half the patients. The delay was commonly after referral to a specialist, and in 17 (31%) patients, was a year or more. A mean delay from the start of symptoms until diagnosis of 20 weeks has been reported previously'". When the dominant presentation was of epigastric pain, with or without vomiting, confusion with peptic ulceration was frequent, even after investigations, and this confirms one other study23. The development of fibre-optic endoscopy raised hopes for increased diagnostic accuracy22, but our study and those of others find that endoscopy is not a reliable technique for the diagnosis of GIL5.18.24. Even when a gastric lesion is biopsied, the pathological diagnosis can be misleading -the biopsy is mucosal, but the tumour originates in the deeper tissues of the gastrointestinal wall.
GIL of the jejunum or ileum may give rise to symptoms that mimic closely those ofCrohn's disease. In this study four patients were thought initially to have Crohn's disease. GIL is also known to occur in Journal of the Royal Society of Medicine Volume 82 November 1989 659 association with coeliac disease'". It is important that any unexplained deterioration inpatients who are thought to have Crohn's disease should be investigated thoroughly, with laparotomy if necessary. Likewise patients with coeliac disease should be closely monitored, although none in our series had coeliac disease.
In many patients in this series (40%) the diagnosis was revealed only after a complication had occurred that required emergency operation. Such complications worsened the prognosis and provided poor circumstances for adequate surgery. This study supports previous reports which indicate that complete excision confers survival benefit 2.6.26. Clearly the extent of surgical resection depends both on the position and bulk of tumour mass and the experience of the operator. Often poor prognosis may well be a reflection of the disease rather than the surgeon's ability to resect it, but in patients with GIL who have had biopsy only, a second operation for 'trial of resection' has been commended as a routine before chemotherapy'S", We would support this -in some patients we found it possible to resect all mucosal disease at a second-look laparotomy. CT scans were useful to predict those patients who could benefit from further operations.
There was a trend in our series for deaths to occur either within six months from the start of treatment, or after 30 months. This agrees with the finding that deaths from GIL are either 'early' or 'late'!'. The 'early' deaths within six months were exclusively the result of complications which occurred during chemotherapy. This is in part a reflection of the efficacy of modem chemotherapy to eradicate residual disease. Residual tumour is often trans-mural, and has a high propensity to bleed or to perforate when subjected to cytotoxic agents 5.20. This reinforces the desirability of radical surgery before cytotoxic chemotherapy. Perforation on chemotherapy is very high risk 1.17 • In one study haemorrhage or perforation during chemotherapy accounted for 38%of treatment failures'". The high mortality which follows these complications is understandable, because the patients are already very ill, with leucopaenia, thrombocytopaenia and immuno-compromise induced by chemotherapy. Laparotomy for abdominal catastrophe in such patients is a hazardous, but necessary, venture.
In summary, GIL is a rare but potentially curable disease to which the surgeon should be alert. Diagnosis is difficult, and misdiagnosis leading to a delay in correct treatment is Common. Prognosis in part depends upon the adequacy of surgical resection, and early diagnosis may allow the best chance for complete excision. Chemotherapy is important, but may be hazardous for patients who have residual trans-mural disease. Complete resection should be attempted wherever possible before chemotherapy, and this may require a 'second-look' laparotomy. Patients undergoing chemotherapy need close observation for signs of gastrointestinal haemorrhage or perforation, in order that early surgical intervention can be given when necessary. The place for surgeons with experience is clearly central to the management of this disease.
